6th Theranostics World Congress

24
Juni

24. - 26. Juni 2022

RheinMain CongressCenter (RMCC) in WiesbadenLink zum ProgrammLink zur Anmeldungin Kalender übernehmen

Veranstalter

Kongress- und Kulturmanagement GmbH
Projektmanagement

Wissenschaftliche Leitung:
Professor Dr. Richard P. Baum

Anmeldung / Organisation

6th Theranostics World Congress
c/o Kongress- und Kulturmanagement GmbH
Rießnerstraße 12B
99427 Weimar

Kontakt: Tina Streitberger
Telefon: 49 3643 2468-169
E-Mail: twc2022@kukm.de

Qualitätsnachweise

Veranstaltungsdetails

Ort
RheinMain CongressCenter (RMCC)
Friedrich-Ebert-Allee 1
65185 Wiesbaden
Deutschland
Thema
Physik und Technik, Uroradiologie/Urogenitaldiagnostik, Onkologische Bildgebung, CT, PET, Hybridbildgebung (PET-MR, PET-CT)
Zielgruppe
Fachärzte, Ärzte in Weiterbildung (AiW), Studenten, Ingenieure / Naturwiss.
Weitere Infos
The TWC 2022 will be a hybrid event, enabling you to attend in-person or online. We want to take a 360° view on the wide field of Theranostics in Radiomolecular Precision Oncology. Some of the topics this year are: Radioisotope Production and Distribution – What is the Future? ▪ Radiochemistry and Radiopharmacy – New Developmentsrn▪ Neuroendocrine Tumors ▪ Prostate Cancer ▪ Novel/other indications/Genetics ▪ Medical Physics/Dosimetry/AI/Instrumentation ▪ FAP, Radioprotectors, Radiosensitizers ▪ Patient Forum/Round Table Discussion.2022 is also the year for the celebration of 25 years of Peptide Receptor Radionuclide Therapy (PRRT) in Germany which started in Frankfurt/Main in 1997. There is certainly a lot to discuss and celebrate! Therefore, it's our great pleasure to welcome you to the 6th Theranostic World Congress from June 24 – 26, 2022, in Wiesbaden, Germany.

Abstract submission

The abstract submission is opened till April 15th, 2022. Abstracts can be submitted for one of the following topics:

Advances in Radiochemistry & Radioisotope Production
▪ Novel isotope production strategies
▪ New radiolabeling approaches
▪ Isotope supply
▪ Advances in chelator chemistry

Clinical Applications
▪ Theranostics for PCa & NET
▪ FAP inhibitors
▪ Novel indications (Adeno-CAs, Sarcomas)

Highlights in Preclinical R&D
▪ New targets and interesting vectors
▪ Strategies for PK improvement (e.g., albumin binders)
▪ Pre-targeting approaches
▪ Multi-modal theranostics

Nuclear Medicine meets Genetics
▪ Genetic reasons for (non)responding

Other/Various

If the abstract is accepted, presenters must register for the congress and pay the registration fee by 31 May 2022. All accepted abstracts will be presented as posters. A limited number of abstracts will be selected for oral presentations.

Teilnahmegebühren

Onsite participation | Regular Congress fee

650,00

Onsite participation | Fellows Fee

80,00

Onsite participation | Patients

0,00

Online participation

250,00

Alle genannten Preise in Euro, sofern nicht anders angegeben.